Creating new pharmaceutical compounds using light and nanocrystals
Light-Induced Atroposelective N-Heterocyclization via Chiral Perovskite Nanocrystals
This study is exploring a new way to make special molecules that can help create better medicines, using light and tiny crystals to make the process easier and cheaper, which could lead to new treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | San Diego State University NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11092732 on NIH RePORTER |
What this research studies
This research focuses on developing a novel method to create chiral N-heterocyclic molecules, which are important for pharmaceutical applications. By utilizing visible light and chiral semiconductor perovskite nanocrystals as catalysts, the project aims to facilitate a direct and efficient reaction that produces these complex molecules. This approach is designed to overcome existing challenges in the synthesis of these compounds, making the process more accessible and cost-effective. Patients may benefit from new and improved medications that arise from this innovative synthesis method.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals interested in novel pharmaceutical treatments or those affected by conditions that could be treated with new medications derived from these compounds.
Not a fit: Patients who are not seeking new pharmaceutical treatments or who do not have conditions that could be addressed by the resulting compounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective pharmaceutical compounds for various health conditions.
How similar studies have performed: This approach is relatively novel, but similar methodologies using light-induced reactions in pharmaceutical synthesis have shown promise in preliminary studies.
Where this research is happening
San Diego, United States
- San Diego State University — San Diego, United States (Active)
Researchers
- Principal investigator: Yan, Yong — San Diego State University
- Study coordinator: Yan, Yong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.